ORBIS BIOSCIENCES INC — Form D/A
ORBIS BIOSCIENCES INC of KANSAS CITY, MO, a company, filed a Form D amendment with the SEC on 2017-04-28. The offering totals $1.1M, of which $985K was reported sold. Industry: Other Technology.
Offering
- Filed: 2017-04-28
- Form: D/A
- Accession: 0001449477-17-000003
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $1.1M
- Amount sold: $985K
- Remaining: $115K
- Investors: 11
- Date of first sale: 2016-10-17
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-273532
Issuer
- Name: ORBIS BIOSCIENCES INC
- CIK: 0001449477
- Entity type: Corporation
- Jurisdiction: DE
- Incorporated: 2007
- Address: 5426 CENTRAL STREET, KANSAS CITY, MO, 64112
- Phone: 913-530-1717
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Cory Berkland | Director | Parkville, MO |
| James Clarke | Director | Seattle, WA |
| Bowman Fishback | Director | Lenexa, KS |
| Maria Flynn | Director | Lenexa, KS |
| Cory Berkland | Executive Officer | Parkville, MO |
| Maria Flynn | Executive Officer | Lenexa, KS |
| Bowman Fishback | Executive Officer | Lenexa, KS |
| James G Clarke | Director | Kansas City, MO |
Other filings by this issuer (2)
More